Press Releases
Veranex Joins Industry Leaders as a Sponsor for the Stanford Byers Center for Biodesign
RALEIGH, N.C.– March 20, 2023 (Business Wire) –Veranex, the only truly comprehensive, global, tech-enabled service provider dedicated to the medtech...
Veranex Acquires Fusion Biotec to Continue Accelerating MedTech Diagnostic Solutions
RALEIGH, N.C.; Dec. 13, 2022 (Business Wire) – Veranex, the only truly comprehensive, global, tech-enabled service provider dedicated to the MedTech industry,...
Veranex Announces Tom Daulton as CEO and Appointment of David Dockhorn to New COO Role
RALEIGH, N.C.; Oct. 20, 2022 (Business Wire) – Veranex, the only truly comprehensive, global, tech-enabled service provider dedicated to the MedTech industry,...
Veranex Acquires Devicia and Clarvin, Expanding Regulatory, Quality, and Clinical Expertise for IVD and Medical Devices
RALEIGH, N.C.; Oct. 11, 2022 (Business Wire) – Veranex, the only truly comprehensive, global, tech-enabled service provider dedicated to the medical technology...
Veranex Expands European MedTech Capabilities With Acquisition of Medidee
RALEIGH, N.C.; Sept. 20, 2022 (Business Wire) – Veranex, the only truly comprehensive, global, tech-enabled service provider dedicated to the medical technology...
Industry Veterans and Experts Join Veranex
RALEIGH, N.C.; May 24, 2022 – Veranex today announced the expansion of the company’s leadership team with the additions of...
News Coverage
Sixth Acquisition Extends Veranex Lead in MedTech Industry Services
Veranex expands global capabilities for human-centered design, innovation, and strategy RALEIGH, N.C.; Dec. 7, 2021 – Veranex, the only global, tech-enabled...
How Long Does It Take to Register a Medical Device/IVD in China?
This article generalizes the process to provide a hyper-simplified answer for investors and CEOs, and sales & marketing executives of MedTech companies, needing this crucial piece of information to make…
Winter Has Come – Aggressive National Programs To Drive Down Drug Costs
China: 2018 was another eventful year for the pharmaceutical industry, highlighted by the Chinese government’s radical attempts to slash drug prices by the annual national drug price negotiation and along…
Defining the value of innovative treatment methods in Germany
A recent proposal by Jens Spahn, Federal Minister for Health in Germany, would limit the decision-making power of the Joint Federal Committee (G-BA) and lead to new evidence approaches for…